Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares
Shares of Liminatus Pharma, Inc. jumped 29.4% to $0.74 during premarket trading Tuesday, on volume of roughly 5.3 million shares. The firm's market cap stood near $15.5 million.